2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis

被引：0
作者：
Alzeer, Ali [1 ]
Zeck, Jay [1 ]
Laureano, Julio [1 ]
Sidawy, Mary [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页数：2
相关论文
共 50 条
  • [31] How Do the Differences Between 2013 and 2007 ASCO/CAP HER2 Guidelines Affect Her2 Status in Breast Carcinomas?
    Onguru, Onder
    Zhang, Paul
    [J]. MODERN PATHOLOGY, 2015, 28 : 59A - 59A
  • [32] How Do the Differences Between 2013 and 2007 ASCO/CAP HER2 Guidelines Affect Her2 Status in Breast Carcinomas?
    Onguru, Onder
    Zhang, Paul
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 59A - 59A
  • [33] Quality improvement analysis of HER2 FISH testing in breast cancer in response to the new ASCO/CAP guidelines
    Fang, M.
    Thalody, V
    Tannenbaum, S.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 208S - 208S
  • [34] Impact of recent 2018 ASCO-CAP HER2 testing guidelines on 2713 breast cancer cases treated according to 2013 ASCO-CAP HER2 guidelines- Western Indian tertiary cancer centre experience
    Pai, Trupti
    Ankolkar, Mandar
    Shetty, Omshree
    Gurav, Mamta
    Dhanavade, Sandeep
    Tambe, Sonali
    Kadam, Vinayak
    Patil, Asawari
    Desai, Sangeeta
    Shet, Tanuja
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [35] Impact of recent 2018 ASCO-CAP HER2 testing guidelines on 2713 breast cancer cases treated according to 2013 ASCO-CAP HER2 guidelines-Western Indian tertiary cancer centre experience
    Pai, Trupti
    Ankolkar, Mandar
    Shetty, Omshree
    Gurav, Mamta
    Dhanavade, Sandeep
    Tambe, Sonali
    Kadam, Vinayak
    Patil, Asawari
    Desai, Sangeeta
    Shet, Tanuja
    [J]. MODERN PATHOLOGY, 2019, 32
  • [36] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Bo Wang
    Wei Ding
    Ke Sun
    Xiaoling Wang
    Liming Xu
    Xiaodong Teng
    [J]. Scientific Reports, 9
  • [37] Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
    Wang, Bo
    Ding, Wei
    Sun, Ke
    Wang, Xiaoling
    Xu, Liming
    Teng, Xiaodong
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [39] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    [J]. MODERN PATHOLOGY, 2019, 32
  • [40] HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines
    Lauren E. McLemore
    Constance T. Albarracin
    Stephen K. Gruschkus
    Roland L. Bassett
    Yun Wu
    Sagar Dhamne
    Isaiah Yim
    Kevin Lin
    Isabelle Bedrosian
    Nour Sneige
    Hui Chen
    [J]. Breast Cancer Research and Treatment, 2021, 187 : 95 - 104
12345